featured
Prevalence of and Reasons for Discontinuation of Continuous Subcutaneous Insulin Infusion in People With Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Technology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prevalence of and Reasons for Discontinuation of Continuous Subcutaneous Insulin Infusion in People with Type 1 Diabetes: A Systematic Review
Diabetes Technol. Ther. 2023 Aug 01;25(8)559-570, P Dekker, HJ Aanstoot, T Sas, M de Vries, E Birnie, D Mul, G NefsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.